Huapont R&D Center
Huapont Pharma R&D system was established in 1998 with an experiment site of over 10,000 square meters area, which equipped with advanced instruments with a total value of more than 60 million. There are more than 200 R&D technical personnel (master’s degree or above or senior professional title researchers are more than 60%). It has successfully developed two new drugs of class 1.5 as a representative of topical drugs for skin use, include psoriasis, acne, dermatitis eczema, urticaria and other skin disease drugs. It has accumulated over 20 years’ rich experience in research and development of skin drugs, as well as the the fields of respiratory, cardiovascular and cerebrovascular diseases, blood, tumors, and systematic glucocorticoids.